Christine Ring Nurix Therapeutics, Inc. (NRIX) insider trading activity

Christine Ring is Chief Legal Officer of Nurix Therapeutics, Inc.. Currently has a direct ownership of 50,897 shares of NRIX, which is worth approximately $651,481. The most recent transaction as insider was on Sep 10, 2021, when has been sold 2,000 shares (Common Stock) at a price of $1.86 per share, resulting in proceeds of $3,720. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 50.9K

15.65% 3M change

81.23% 12M change

Total Value Held $651,481

Christine Ring Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 10 2021	BUY Exercise of conversion of derivative security	$3,720 $1.86 p/Share	2,000 Added 37.84%	3,286 Common Stock
Sep 07 2021	SELL Open market or private sale	$112,800 $35.25 p/Share	3,200 Reduced 71.33%	1,286 Common Stock
Sep 07 2021	BUY Exercise of conversion of derivative security	$5,952 $1.86 p/Share	3,200 Added 41.63%	4,486 Common Stock
Aug 10 2021	SELL Open market or private sale	$35,844 $29.87 p/Share	1,200 Reduced 59.85%	805 Common Stock
Aug 10 2021	BUY Exercise of conversion of derivative security	$2,232 $1.86 p/Share	1,200 Added 37.44%	2,005 Common Stock
Jul 20 2021	SELL Open market or private sale	$32,400 $27.0 p/Share	1,200 Reduced 59.85%	805 Common Stock
Jul 20 2021	BUY Exercise of conversion of derivative security	$2,232 $1.86 p/Share	1,200 Added 37.44%	2,005 Common Stock

Jun 10 2021	SELL Open market or private sale	$35,820 $29.85 p/Share	1,200 Reduced 59.85%	805 Common Stock
Jun 10 2021	BUY Exercise of conversion of derivative security	$2,232 $1.86 p/Share	1,200 Added 37.44%	2,005 Common Stock
May 10 2021	SELL Open market or private sale	$32,400 $27.0 p/Share	1,200 Reduced 59.85%	805 Common Stock
May 10 2021	BUY Exercise of conversion of derivative security	$2,232 $1.86 p/Share	1,200 Added 37.44%	2,005 Common Stock
Apr 28 2021	SELL Open market or private sale	$28,200 $35.25 p/Share	800 Reduced 49.84%	805 Common Stock
Apr 28 2021	BUY Exercise of conversion of derivative security	$1,488 $1.86 p/Share	800 Added 33.26%	1,605 Common Stock
Apr 12 2021	SELL Open market or private sale	$32,640 $27.2 p/Share	1,200 Reduced 59.85%	805 Common Stock
Apr 12 2021	BUY Exercise of conversion of derivative security	$2,232 $1.86 p/Share	1,200 Added 37.44%	2,005 Common Stock
Mar 10 2021	SELL Open market or private sale	$83,680 $41.84 p/Share	2,000 Reduced 71.3%	805 Common Stock
Mar 10 2021	BUY Exercise of conversion of derivative security	$3,720 $1.86 p/Share	2,000 Added 41.62%	2,805 Common Stock
Feb 18 2021	SELL Open market or private sale	$71,580 $35.79 p/Share	2,000 Reduced 100.0%	0 Common Stock
Feb 18 2021	BUY Exercise of conversion of derivative security	$3,720 $1.86 p/Share	2,000 Added 50.0%	2,000 Common Stock

Christine Ring

Chief Legal Officer

San Francisco, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRIX shares.

Notify only if

Value

Insider Trading

Get notified when an Nurix Therapeutics, Inc. insider buys or sells NRIX shares.

Notify only if

Operation

Value

Type

News

Receive news related to Nurix Therapeutics, Inc.

Track Activities on NRIX

Account